spacer
home > ebr > summer 2002 > gene therapy for damaged nerves
PUBLICATIONS
European Biopharmaceutical Review

Gene Therapy for Damaged Nerves

It has long been recognised that cells from the peripheral nervous system (PNS) can regenerate. In contrast, the adult brain and spinal cord (or central nervous system [CNS]) does not regenerate under normal conditions. This poses major problems to patients and their neurologists, as there are currently no treatments available to promote regeneration of injured brain or spinal cord tissue.The study of the fundamental cellular and molecular mechanisms that underlie successful regeneration in the PNS (and its failure in the CNS) form the overall objective of the neuroregeneration team at the Netherlands Institute for Brain Research (NIBR) in Amsterdam. Headed by Professor Joost Verhaagen, the group is investigating strategies to promote neuroregeneration and axonal outgrowth. These could then be employed in the treatment of spinal cord injuries and also neurodegenerative diseases such as Alzheimer's.One approach employed by the team is gene therapy, using viral vectors to deliver genes that are functional or up-regulated in regenerating PNS tissue to brain or spinal cord tissue that does not re-grow. Gene therapy is still a relatively young science - the first human gene therapy trials began in 1990 using an ex vivo method.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Andreas Rьhlmann, European Bioinformatics and Microarray Specialist at Agilent Technologies

Dr Andreas Rьhlmann studied Physics and Chemistry at the University of Hamburg and Gцttingen and holds a degree in Organic Chemistry and a doctorate in Biochemistry from the University of Gцttingen/University of Braunschweig.
He worked as a Research Scientist at Harvard Medical School, Hannover Medical School and at the University of Tьbingen, mainly on gene regulation and signal transduction, as well as in clinical chemistry at the University of Magdeburg. He joined Agilent in June 2000 and serves as a European Bioinformatics and Microarray Specialist.

spacer
Dr Andreas Rьhlmann
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Peli BioThermal showcase CoolPall™ Flex and industry leading solutions at Temperature Control and Logistics Conference

Peli BioThermal, the global name in temperature-controlled packaging, is exhibiting its industry leading shipper systems, including its innovative CoolPall™ Flex, at the 19th Annual Cool Chain Temperature Control and Logistics conference.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement